These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18496568)

  • 1. Autocrine actions of matrix metalloproteinase (MMP)-2 counter the effects of MMP-9 to promote survival and prevent terminal differentiation of cultured human keratinocytes.
    Xue M; Jackson CJ
    J Invest Dermatol; 2008 Nov; 128(11):2676-2685. PubMed ID: 18496568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
    Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
    Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 and ERK Signaling Pathways Are Implicated in the Invasion Activity by Oncostatin M through Induction of Matrix Metalloproteinases 2 and 9.
    Ko HS; Park BJ; Choi SK; Kang HK; Kim A; Kim HS; Park IY; Shin JC
    Yonsei Med J; 2016 May; 57(3):761-8. PubMed ID: 26996579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation.
    Xue M; McKelvey K; Shen K; Minhas N; March L; Park SY; Jackson CJ
    Rheumatology (Oxford); 2014 Dec; 53(12):2270-9. PubMed ID: 24982240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
    Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
    J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes.
    Lan CC; Liu IH; Fang AH; Wen CH; Wu CS
    Br J Dermatol; 2008 Nov; 159(5):1103-15. PubMed ID: 18717678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
    Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
    Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C stimulates proliferation, migration and wound closure, inhibits apoptosis and upregulates MMP-2 activity in cultured human keratinocytes.
    Xue M; Thompson P; Kelso I; Jackson C
    Exp Cell Res; 2004 Sep; 299(1):119-27. PubMed ID: 15302579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP-14 mediated MMP-9 expression is involved in TGF-beta1-induced keratinocyte migration.
    Seomun Y; Kim JT; Joo CK
    J Cell Biochem; 2008 Jun; 104(3):934-41. PubMed ID: 18307173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras-transfection up-regulated HaCaT cell migration: inhibition by Marimastat.
    Charvat S; Le Griel C; Chignol MC; Schmitt D; Serres M
    Clin Exp Metastasis; 1999; 17(8):677-85. PubMed ID: 10919713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes.
    Zeigler ME; Chi Y; Schmidt T; Varani J
    J Cell Physiol; 1999 Aug; 180(2):271-84. PubMed ID: 10395297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes.
    Zhu P; Ren M; Yang C; Hu YX; Ran JM; Yan L
    Exp Dermatol; 2012 Feb; 21(2):123-9. PubMed ID: 22229442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AP-1 inhibits expression of MMP-2/9 and its effects on rat smooth muscle cells.
    Zhang HW; Wang X; Zong ZH; Huo X; Zhang Q
    J Surg Res; 2009 Nov; 157(1):e31-7. PubMed ID: 19524937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CD9 in keratinocyte contributes to cell migration via upregulation of matrix metalloproteinase-9.
    Jiang XP; Zhang DX; Teng M; Zhang Q; Zhang JP; Huang YS
    PLoS One; 2013; 8(10):e77806. PubMed ID: 24147081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a gelatin hydrogel incorporating epiregulin on human keratinocyte growth.
    Renò F; Rizzi M; Cannas M
    J Biomater Sci Polym Ed; 2012; 23(16):2025-38. PubMed ID: 22023724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway.
    Liu WH; Chang LS
    J Cell Physiol; 2010 Sep; 224(3):775-85. PubMed ID: 20432471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW; Leung PC; Wong AS
    Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone inhibits proliferation, motility, and matrix metalloproteinase production in keratinocytes.
    Bhagavathula N; Nerusu KC; Lal A; Ellis CN; Chittiboyina A; Avery MA; Ho CI; Benson SC; Pershadsingh HA; Kurtz TW; Varani J
    J Invest Dermatol; 2004 Jan; 122(1):130-9. PubMed ID: 14962101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src promotes cutaneous wound healing by regulating MMP-2 through the ERK pathway.
    Wu X; Yang L; Zheng Z; Li Z; Shi J; Li Y; Han S; Gao J; Tang C; Su L; Hu D
    Int J Mol Med; 2016 Mar; 37(3):639-48. PubMed ID: 26821191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.